{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Stocks Rag\n",
    "\n",
    "Author: Orvin Bellamy (https://github.com/orvinbellamy)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "## Import libraries\n",
    "\n",
    "import yfinance as yf\n",
    "import pandas as pd\n",
    "import openai\n",
    "from openai import OpenAI\n",
    "import os\n",
    "import json\n",
    "import fs\n",
    "import time\n",
    "from dotenv import load_dotenv\n",
    "import logging as log\n",
    "from matplotlib import pyplot as plt\n",
    "from matplotlib import image as mpimg\n",
    "from filehandler import FileHandler\n",
    "from yfinancehandler import YFHandler\n",
    "from eventhandler import EventHandler, ThreadManager\n",
    "from agenthandler import AgentHandler\n",
    "from stockanalyzer import analyze_stock, stock_data_setup\n",
    "import importlib"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "## configruation\n",
    "\n",
    "FILE_PATH = 'openai_upload_files/'\n",
    "OPENAI_DIC_FILE_NAME = 'openai_files.json'\n",
    "\n",
    "# Load schemas from JSON file\n",
    "with open('config/dataframe_schemas.json', 'r') as f:\n",
    "    schemas = json.load(f)\n",
    "\n",
    "# Initialize an empty list to store the stocks\n",
    "stocks_list = []\n",
    "\n",
    "# Open dic_files\n",
    "with open(f'{FILE_PATH}{OPENAI_DIC_FILE_NAME}', 'r') as f:\n",
    "    dic_files = json.load(f)\n",
    "\n",
    "with open('config/assistants.json', 'r') as json_file:\n",
    "    dic_assistants= json.load(json_file)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Stocks Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "analysis = analyze_stock(\n",
    "\tticker= ['MSFT'], \n",
    "\tdic_files=dic_files,\n",
    "\tdic_assistants=dic_assistants\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'analysis' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[5], line 1\u001b[0m\n\u001b[1;32m----> 1\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[43manalysis\u001b[49m)\n",
      "\u001b[1;31mNameError\u001b[0m: name 'analysis' is not defined"
     ]
    }
   ],
   "source": [
    "print(analysis)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "d:\\Documents\\Python Repo\\stock_rag\\yfinancehandler.py:20: FutureWarning: The behavior of DataFrame concatenation with empty or all-NA entries is deprecated. In a future version, this will no longer exclude empty or all-NA columns when determining the result dtypes. To retain the old behavior, exclude the relevant entries before the concat operation.\n",
      "  df = pd.concat([df, df_plc], ignore_index=True)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "file name: df_stocks.csv, file id: file-Tefw5m8pdLpmdhiM1KsqI4rF has been deleted\n",
      "file name: df_stocks.csv is uploaded, new file id: file-aGcHBmPdH14sXdEEipa89VXN\n",
      "openai_upload_files/openai_files.json file has been updated\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "d:\\Documents\\Python Repo\\stock_rag\\yfinancehandler.py:34: FutureWarning: The behavior of DataFrame concatenation with empty or all-NA entries is deprecated. In a future version, this will no longer exclude empty or all-NA columns when determining the result dtypes. To retain the old behavior, exclude the relevant entries before the concat operation.\n",
      "  df = pd.concat([df, df_plc], ignore_index=True)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "file name: df_cashflow.csv, file id: file-I2tQB4Bkjyv9jEprAt1xUxG7 has been deleted\n",
      "file name: df_cashflow.csv is uploaded, new file id: file-McebaeiomNJMW1qsiq0yXHAu\n",
      "openai_upload_files/openai_files.json file has been updated\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "d:\\Documents\\Python Repo\\stock_rag\\yfinancehandler.py:48: FutureWarning: The behavior of DataFrame concatenation with empty or all-NA entries is deprecated. In a future version, this will no longer exclude empty or all-NA columns when determining the result dtypes. To retain the old behavior, exclude the relevant entries before the concat operation.\n",
      "  df = pd.concat([df, df_plc], ignore_index=True)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "file name: df_income_stmt.csv, file id: file-WOPOtII6xsbhScFbnjenBnS9 has been deleted\n",
      "file name: df_income_stmt.csv is uploaded, new file id: file-N7s7SaE2oanvYlYwZKU4IC8s\n",
      "openai_upload_files/openai_files.json file has been updated\n",
      "assistants.json file has been updated\n",
      "Assistant has been updated, name: fin_analyst, id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "Assistant has been updated, name: fin_consultant, id: asst_mPlBQ4ZF8YIF238DWqWRhV4U\n"
     ]
    }
   ],
   "source": [
    "ticker = ['MRNA']\n",
    "\n",
    "client = OpenAI()\n",
    "\n",
    "file_stocks = stock_data_setup(client=client, ticker=ticker, type='price', dic_files=dic_files)\n",
    "file_cashflow = stock_data_setup(client=client, ticker=ticker, type='cash', dic_files=dic_files)\n",
    "file_income_stmt = stock_data_setup(client=client, ticker=ticker, type='income', dic_files=dic_files)\n",
    "\n",
    "# Have to manually update the tool_resources because the file_id can change\n",
    "dic_assistants['fin_analyst']['tool_resources'] = {\n",
    "\t'code_interpreter': {'file_ids': [dic_files['df_stocks.csv']]}\n",
    "}\n",
    "\n",
    "with open('config/assistants.json', 'w') as json_file:\n",
    "\tjson.dump(dic_assistants, json_file)\n",
    "\tprint(f'assistants.json file has been updated')\n",
    "\n",
    "fin_analyst = AgentHandler(\n",
    "\tclient = client, \n",
    "\tnew=False,\n",
    "\tassistant_name = 'fin_analyst',\n",
    "\tdic_file = dic_assistants,\n",
    "\tdic_file_name = 'assistants.json',\n",
    "\tdic_file_path='config/'\n",
    "\t)\n",
    "\n",
    "fin_consultant = AgentHandler(\n",
    "\tclient = client,\n",
    "\tnew=False,\n",
    "\tassistant_name = 'fin_consultant',\n",
    "\tdic_file = dic_assistants,\n",
    "\tdic_file_name = 'assistants.json',\n",
    "\tdic_file_path='config/'\n",
    "\t)\n",
    "\n",
    "# prompt_start = f\"This is your client. I want you to advice me on the stocks I list below.\\\n",
    "# \tI want to know the stocks' performance, if they're overvalued or undervalued, and whether or not they'll be a good investment.\\\n",
    "# \tI am looking for a long term (5+ years) investment and I have a relatively high risk tolerance.\\\n",
    "# \tStocks: {ticker}\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "assistant > code_interpreter\n",
      "\n",
      "import pandas as pd\n",
      "\n",
      "# Load the data from the CSV file\n",
      "file_path = '/mnt/data/file-aGcHBmPdH14sXdEEipa89VXN'\n",
      "stock_data = pd.read_csv(file_path)\n",
      "\n",
      "# Display the first few rows of the dataframe to understand its structure\n",
      "stock_data.head()\n",
      "assistant > Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "The provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\n",
      "- Date\n",
      "- Open\n",
      "- High\n",
      "- Low\n",
      "- Close\n",
      "- Volume\n",
      "- Dividends\n",
      "- Stock Splits\n",
      "- Ticker\n",
      "\n",
      "### Steps for Analysis:\n",
      "1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\n",
      "2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\n",
      "3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\n",
      "4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\n",
      "\n",
      "Let's start by performing these analyses.import numpy as np\n",
      "\n",
      "# Convert date column to datetime\n",
      "stock_data['Date'] = pd.to_datetime(stock_data['Date'])\n",
      "\n",
      "# Calculate moving averages\n",
      "stock_data['MA_50'] = stock_data['Close'].rolling(window=50).mean()\n",
      "stock_data['MA_200'] = stock_data['Close'].rolling(window=200).mean()\n",
      "\n",
      "# Calculate daily returns\n",
      "stock_data['Daily_Return'] = stock_data['Close'].pct_change()\n",
      "\n",
      "# Summary statistics\n",
      "summary_stats = stock_data.describe()\n",
      "\n",
      "# Latest values for key metrics\n",
      "latest_data = stock_data.tail(1)  # Most recent data\n",
      "ma_50_latest = latest_data['MA_50'].values[0]\n",
      "ma_200_latest = latest_data['MA_200'].values[0]\n",
      "latest_close = latest_data['Close'].values[0]\n",
      "\n",
      "summary_stats, latest_close, ma_50_latest, ma_200_latest\n",
      "assistant > Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "### Analysis Summary for Moderna (MRNA):\n",
      "\n",
      "#### Historical Price Analysis:\n",
      "- **Current Closing Price:** \\$68.28\n",
      "- **Average Close Price:** \\$118.85 (over the analyzed period)\n",
      "- **52-Week High:** \\$484.47\n",
      "- **52-Week Low:** \\$12.26\n",
      "\n",
      "#### Moving Averages:\n",
      "- **50-Day Moving Average (MA_50):** \\$95.88\n",
      "- **200-Day Moving Average (MA_200):** \\$106.16\n",
      "\n",
      "#### Volume Analysis:\n",
      "- **Average Daily Trading Volume:** 8.08 million shares\n",
      "- **High Trading Volume:** Up to 125.13 million shares\n",
      "- **Low Trading Volume:** As low as 272.8 thousand shares\n",
      "\n",
      "#### Volatility:\n",
      "- **Standard Deviation of Daily Returns:** 4.63%\n",
      "- **Average Daily Return:** 0.20%\n",
      "- **Daily Return Range:** -21.01% to 27.81%\n",
      "\n",
      "### Key Observations:\n",
      "- The current price of \\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\n",
      "- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\n",
      "- No dividend payouts or stock splits have been recorded historically for MRNA.\n",
      "\n",
      "The financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.get_last_message initiated\n",
      "message_id: msg_ATqDH6NCl043TLvKdGCdSGyr, assistant_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "asst_id = blank\n",
      "new_message: Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "### Analysis Summary for Moderna (MRNA):\n",
      "\n",
      "#### Historical Price Analysis:\n",
      "- **Current Closing Price:** \\$68.28\n",
      "- **Average Close Price:** \\$118.85 (over the analyzed period)\n",
      "- **52-Week High:** \\$484.47\n",
      "- **52-Week Low:** \\$12.26\n",
      "\n",
      "#### Moving Averages:\n",
      "- **50-Day Moving Average (MA_50):** \\$95.88\n",
      "- **200-Day Moving Average (MA_200):** \\$106.16\n",
      "\n",
      "#### Volume Analysis:\n",
      "- **Average Daily Trading Volume:** 8.08 million shares\n",
      "- **High Trading Volume:** Up to 125.13 million shares\n",
      "- **Low Trading Volume:** As low as 272.8 thousand shares\n",
      "\n",
      "#### Volatility:\n",
      "- **Standard Deviation of Daily Returns:** 4.63%\n",
      "- **Average Daily Return:** 0.20%\n",
      "- **Daily Return Range:** -21.01% to 27.81%\n",
      "\n",
      "### Key Observations:\n",
      "- The current price of \\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\n",
      "- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\n",
      "- No dividend payouts or stock splits have been recorded historically for MRNA.\n",
      "\n",
      "The financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\n",
      "message_id: msg_6BDuEalmOKp190jDOumG56iB, assistant_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id == asst_id, proceed normally to collect message\n",
      "new_message: Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "The provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\n",
      "- Date\n",
      "- Open\n",
      "- High\n",
      "- Low\n",
      "- Close\n",
      "- Volume\n",
      "- Dividends\n",
      "- Stock Splits\n",
      "- Ticker\n",
      "\n",
      "### Steps for Analysis:\n",
      "1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\n",
      "2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\n",
      "3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\n",
      "4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\n",
      "\n",
      "Let's start by performing these analyses.\n",
      "message_id: msg_dy4lz80kcSMTj2CPUe5fyIXq, assistant_id: None\n",
      "message.id in existing_message_id, ending function\n",
      "{'message_id': 'msg_6BDuEalmOKp190jDOumG56iB', 'assistant_id': 'asst_Mqf9cO1sDTOd4UMYwcFfIQrA', 'created_at': 1726350036, 'file_ids': [], 'role': 'assistant', 'run_id': 'run_mDRVe3YXrbCartQsh6C8rco9', 'message_text': \"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"}\n",
      "\n",
      "assistant > ### Recommendation for Moderna (MRNA):\n",
      "\n",
      "#### Key Strengths:\n",
      "1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\n",
      "2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\n",
      "3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\n",
      "\n",
      "#### Key Weaknesses:\n",
      "1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\n",
      "2. **Below Key Moving Averages:** The current closing price (\\$68.28) is well below the 50-day (\\$95.88) and 200-day (\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\n",
      "3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\n",
      "\n",
      "### Fit with Client's Investment Strategy:\n",
      "- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\n",
      "- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\n",
      "\n",
      "### Professional Recommendation:\n",
      "Based on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\n",
      "\n",
      "Please let me know if you need further detailed analysis or any additional information!get_last_message initiated\n",
      "message_id: msg_T4gMWhbAIpFcj6D3f4WYcqCR, assistant_id: asst_mPlBQ4ZF8YIF238DWqWRhV4U\n",
      "asst_id = blank\n",
      "new_message: ### Recommendation for Moderna (MRNA):\n",
      "\n",
      "#### Key Strengths:\n",
      "1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\n",
      "2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\n",
      "3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\n",
      "\n",
      "#### Key Weaknesses:\n",
      "1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\n",
      "2. **Below Key Moving Averages:** The current closing price (\\$68.28) is well below the 50-day (\\$95.88) and 200-day (\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\n",
      "3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\n",
      "\n",
      "### Fit with Client's Investment Strategy:\n",
      "- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\n",
      "- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\n",
      "\n",
      "### Professional Recommendation:\n",
      "Based on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\n",
      "\n",
      "Please let me know if you need further detailed analysis or any additional information!\n",
      "message_id: msg_qWHctlMUriq6M4P7fxWzr3t5, assistant_id: None\n",
      "message.assistant_id != asst_id, record previous message first\n",
      "[\"### Recommendation for Moderna (MRNA):\\n\\n#### Key Strengths:\\n1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\\n2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\\n3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\\n\\n#### Key Weaknesses:\\n1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\\n2. **Below Key Moving Averages:** The current closing price (\\\\$68.28) is well below the 50-day (\\\\$95.88) and 200-day (\\\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\\n3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\\n\\n### Fit with Client's Investment Strategy:\\n- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\\n- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\\n\\n### Professional Recommendation:\\nBased on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\\n\\nPlease let me know if you need further detailed analysis or any additional information!\"]\n",
      "{'message_id': 'msg_T4gMWhbAIpFcj6D3f4WYcqCR', 'assistant_id': 'asst_mPlBQ4ZF8YIF238DWqWRhV4U', 'created_at': 1726350052, 'file_ids': [], 'role': 'assistant', 'run_id': 'run_CKU8trY0NhL8pRV5GpeNgbqC', 'message_text': \"### Recommendation for Moderna (MRNA):\\n\\n#### Key Strengths:\\n1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\\n2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\\n3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\\n\\n#### Key Weaknesses:\\n1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\\n2. **Below Key Moving Averages:** The current closing price (\\\\$68.28) is well below the 50-day (\\\\$95.88) and 200-day (\\\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\\n3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\\n\\n### Fit with Client's Investment Strategy:\\n- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\\n- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\\n\\n### Professional Recommendation:\\nBased on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\\n\\nPlease let me know if you need further detailed analysis or any additional information!\"}\n",
      "[]\n",
      "new_message: Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "The provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\n",
      "- Date\n",
      "- Open\n",
      "- High\n",
      "- Low\n",
      "- Close\n",
      "- Volume\n",
      "- Dividends\n",
      "- Stock Splits\n",
      "- Ticker\n",
      "\n",
      "### Steps for Analysis:\n",
      "1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\n",
      "2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\n",
      "3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\n",
      "4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\n",
      "\n",
      "Let's start by performing these analyses.\n",
      "Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "### Analysis Summary for Moderna (MRNA):\n",
      "\n",
      "#### Historical Price Analysis:\n",
      "- **Current Closing Price:** \\$68.28\n",
      "- **Average Close Price:** \\$118.85 (over the analyzed period)\n",
      "- **52-Week High:** \\$484.47\n",
      "- **52-Week Low:** \\$12.26\n",
      "\n",
      "#### Moving Averages:\n",
      "- **50-Day Moving Average (MA_50):** \\$95.88\n",
      "- **200-Day Moving Average (MA_200):** \\$106.16\n",
      "\n",
      "#### Volume Analysis:\n",
      "- **Average Daily Trading Volume:** 8.08 million shares\n",
      "- **High Trading Volume:** Up to 125.13 million shares\n",
      "- **Low Trading Volume:** As low as 272.8 thousand shares\n",
      "\n",
      "#### Volatility:\n",
      "- **Standard Deviation of Daily Returns:** 4.63%\n",
      "- **Average Daily Return:** 0.20%\n",
      "- **Daily Return Range:** -21.01% to 27.81%\n",
      "\n",
      "### Key Observations:\n",
      "- The current price of \\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\n",
      "- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\n",
      "- No dividend payouts or stock splits have been recorded historically for MRNA.\n",
      "\n",
      "The financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\n",
      "[\"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"]\n",
      "message_id: msg_ATqDH6NCl043TLvKdGCdSGyr, assistant_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id != asst_id, record previous message first\n",
      "[\"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"]\n",
      "{'message_id': 'msg_qWHctlMUriq6M4P7fxWzr3t5', 'assistant_id': None, 'created_at': 1726350052, 'file_ids': [], 'role': 'user', 'run_id': None, 'message_text': \"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"}\n",
      "[]\n",
      "new_message: Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "### Analysis Summary for Moderna (MRNA):\n",
      "\n",
      "#### Historical Price Analysis:\n",
      "- **Current Closing Price:** \\$68.28\n",
      "- **Average Close Price:** \\$118.85 (over the analyzed period)\n",
      "- **52-Week High:** \\$484.47\n",
      "- **52-Week Low:** \\$12.26\n",
      "\n",
      "#### Moving Averages:\n",
      "- **50-Day Moving Average (MA_50):** \\$95.88\n",
      "- **200-Day Moving Average (MA_200):** \\$106.16\n",
      "\n",
      "#### Volume Analysis:\n",
      "- **Average Daily Trading Volume:** 8.08 million shares\n",
      "- **High Trading Volume:** Up to 125.13 million shares\n",
      "- **Low Trading Volume:** As low as 272.8 thousand shares\n",
      "\n",
      "#### Volatility:\n",
      "- **Standard Deviation of Daily Returns:** 4.63%\n",
      "- **Average Daily Return:** 0.20%\n",
      "- **Daily Return Range:** -21.01% to 27.81%\n",
      "\n",
      "### Key Observations:\n",
      "- The current price of \\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\n",
      "- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\n",
      "- No dividend payouts or stock splits have been recorded historically for MRNA.\n",
      "\n",
      "The financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\n",
      "['Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.']\n",
      "message_id: msg_6BDuEalmOKp190jDOumG56iB, assistant_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.id in existing_message_id, ending function\n",
      "{'message_id': 'msg_ATqDH6NCl043TLvKdGCdSGyr', 'assistant_id': 'asst_Mqf9cO1sDTOd4UMYwcFfIQrA', 'created_at': 1726350044, 'file_ids': [], 'role': 'assistant', 'run_id': 'run_mDRVe3YXrbCartQsh6C8rco9', 'message_text': 'Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.'}\n"
     ]
    }
   ],
   "source": [
    "prompt_start = f\"This is the financial consultant.\\\n",
    "\tThe client wants advice on the following stocks.\\\n",
    "\tI need you to provide me your analysis on these stocks so I can provide the appropriate recommendations.\\\n",
    "\tYou will be provided with the data of these stocks in .csv format. Use them as you see fit.\\\n",
    "\tStocks: {ticker}\"\n",
    "\n",
    "thread = ThreadManager(\n",
    "\tclient=client,\n",
    "\tprompt=prompt_start\n",
    ")\n",
    "\n",
    "thread.run_thread(\n",
    "\tassistant=fin_analyst\n",
    "\t# prompt=prompt_start,\n",
    "\t# attachments=[file_stocks.file_id, file_cashflow.file_id, file_income_stmt.file_id]\n",
    ")\n",
    "\n",
    "next_prompt = thread.last_message\n",
    "\n",
    "thread.run_thread(\n",
    "\tassistant=fin_consultant,\n",
    "\tprompt=next_prompt\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "This message is for testing. Can you give a short sample response.\n"
     ]
    }
   ],
   "source": [
    "next_prompt = 'This message is for testing. Can you give a short sample response.'\n",
    "\n",
    "thread.run_thread(\n",
    "\tassistant=fin_consultant,\n",
    "\tprompt=next_prompt\n",
    ")\n",
    "\n",
    "print(thread.last_message)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Message(id='msg_zqvD0gadE9hib0XfNfbS57CC', assistant_id='asst_mPlBQ4ZF8YIF238DWqWRhV4U', attachments=[], completed_at=None, content=[TextContentBlock(text=Text(annotations=[], value='### Recommendation for Moderna (MRNA):\\n\\n#### Key Points:\\n- **Current Price:** \\\\$68.28\\n- **Volatility:** High\\n- **Growth Potential:** Strong in mRNA technology\\n- **Dividends:** None\\n\\n#### Recommendation:\\nMRNA is suitable for growth-oriented investors willing to accept high risk for potential high returns. It may not be ideal for conservative or income-seeking investors due to its volatility and lack of dividends.\\n\\nLet me know if you need further details!'), type='text')], created_at=1726350085, incomplete_at=None, incomplete_details=None, metadata={}, object='thread.message', role='assistant', run_id='run_AFZhMbGJZSP5LrDRYHsMJDgD', status=None, thread_id='thread_uwelojSRusp6Zy4aWBAjYxwz'),\n",
       " Message(id='msg_6hilKxJmcKKogiyy5s4RaL8u', assistant_id=None, attachments=[], completed_at=None, content=[TextContentBlock(text=Text(annotations=[], value='This message is for testing. Can you give a short sample response.'), type='text')], created_at=1726350084, incomplete_at=None, incomplete_details=None, metadata={}, object='thread.message', role='user', run_id=None, status=None, thread_id='thread_uwelojSRusp6Zy4aWBAjYxwz'),\n",
       " Message(id='msg_T4gMWhbAIpFcj6D3f4WYcqCR', assistant_id='asst_mPlBQ4ZF8YIF238DWqWRhV4U', attachments=[], completed_at=None, content=[TextContentBlock(text=Text(annotations=[], value=\"### Recommendation for Moderna (MRNA):\\n\\n#### Key Strengths:\\n1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\\n2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\\n3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\\n\\n#### Key Weaknesses:\\n1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\\n2. **Below Key Moving Averages:** The current closing price (\\\\$68.28) is well below the 50-day (\\\\$95.88) and 200-day (\\\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\\n3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\\n\\n### Fit with Client's Investment Strategy:\\n- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\\n- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\\n\\n### Professional Recommendation:\\nBased on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\\n\\nPlease let me know if you need further detailed analysis or any additional information!\"), type='text')], created_at=1726350052, incomplete_at=None, incomplete_details=None, metadata={}, object='thread.message', role='assistant', run_id='run_CKU8trY0NhL8pRV5GpeNgbqC', status=None, thread_id='thread_uwelojSRusp6Zy4aWBAjYxwz'),\n",
       " Message(id='msg_qWHctlMUriq6M4P7fxWzr3t5', assistant_id=None, attachments=[], completed_at=None, content=[TextContentBlock(text=Text(annotations=[], value=\"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"), type='text')], created_at=1726350052, incomplete_at=None, incomplete_details=None, metadata={}, object='thread.message', role='user', run_id=None, status=None, thread_id='thread_uwelojSRusp6Zy4aWBAjYxwz'),\n",
       " Message(id='msg_ATqDH6NCl043TLvKdGCdSGyr', assistant_id='asst_Mqf9cO1sDTOd4UMYwcFfIQrA', attachments=[], completed_at=None, content=[TextContentBlock(text=Text(annotations=[], value='Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.'), type='text')], created_at=1726350044, incomplete_at=None, incomplete_details=None, metadata={}, object='thread.message', role='assistant', run_id='run_mDRVe3YXrbCartQsh6C8rco9', status=None, thread_id='thread_uwelojSRusp6Zy4aWBAjYxwz'),\n",
       " Message(id='msg_6BDuEalmOKp190jDOumG56iB', assistant_id='asst_Mqf9cO1sDTOd4UMYwcFfIQrA', attachments=[], completed_at=None, content=[TextContentBlock(text=Text(annotations=[], value=\"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\"), type='text')], created_at=1726350036, incomplete_at=None, incomplete_details=None, metadata={}, object='thread.message', role='assistant', run_id='run_mDRVe3YXrbCartQsh6C8rco9', status=None, thread_id='thread_uwelojSRusp6Zy4aWBAjYxwz'),\n",
       " Message(id='msg_dy4lz80kcSMTj2CPUe5fyIXq', assistant_id=None, attachments=[], completed_at=None, content=[TextContentBlock(text=Text(annotations=[], value=\"This is the financial consultant.\\tThe client wants advice on the following stocks.\\tI need you to provide me your analysis on these stocks so I can provide the appropriate recommendations.\\tYou will be provided with the data of these stocks in .csv format. Use them as you see fit.\\tStocks: ['MRNA']\"), type='text')], created_at=1726350030, incomplete_at=None, incomplete_details=None, metadata={}, object='thread.message', role='user', run_id=None, status=None, thread_id='thread_uwelojSRusp6Zy4aWBAjYxwz')]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "thread.df_messages\n",
    "client.beta.threads.messages.list(thread_id=thread.thread_id).data\n",
    "# messages_data[0]\n",
    "# type(file_cashflow)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'message_id': 'msg_dy4lz80kcSMTj2CPUe5fyIXq',\n",
       "  'assistant_id': None,\n",
       "  'created_at': 1726350030,\n",
       "  'file_ids': [],\n",
       "  'role': 'user',\n",
       "  'run_id': None,\n",
       "  'message_text': \"This is the financial consultant.\\tThe client wants advice on the following stocks.\\tI need you to provide me your analysis on these stocks so I can provide the appropriate recommendations.\\tYou will be provided with the data of these stocks in .csv format. Use them as you see fit.\\tStocks: ['MRNA']\"},\n",
       " {'message_id': 'msg_zqvD0gadE9hib0XfNfbS57CC',\n",
       "  'assistant_id': 'asst_mPlBQ4ZF8YIF238DWqWRhV4U',\n",
       "  'created_at': 1726350085,\n",
       "  'file_ids': [],\n",
       "  'role': 'assistant',\n",
       "  'run_id': 'run_AFZhMbGJZSP5LrDRYHsMJDgD',\n",
       "  'message_text': '### Recommendation for Moderna (MRNA):\\n\\n#### Key Points:\\n- **Current Price:** \\\\$68.28\\n- **Volatility:** High\\n- **Growth Potential:** Strong in mRNA technology\\n- **Dividends:** None\\n\\n#### Recommendation:\\nMRNA is suitable for growth-oriented investors willing to accept high risk for potential high returns. It may not be ideal for conservative or income-seeking investors due to its volatility and lack of dividends.\\n\\nLet me know if you need further details!'},\n",
       " {'message_id': 'msg_6hilKxJmcKKogiyy5s4RaL8u',\n",
       "  'assistant_id': None,\n",
       "  'created_at': 1726350084,\n",
       "  'file_ids': [],\n",
       "  'role': 'user',\n",
       "  'run_id': None,\n",
       "  'message_text': 'This message is for testing. Can you give a short sample response.'},\n",
       " {'message_id': 'msg_T4gMWhbAIpFcj6D3f4WYcqCR',\n",
       "  'assistant_id': 'asst_mPlBQ4ZF8YIF238DWqWRhV4U',\n",
       "  'created_at': 1726350052,\n",
       "  'file_ids': [],\n",
       "  'role': 'assistant',\n",
       "  'run_id': 'run_CKU8trY0NhL8pRV5GpeNgbqC',\n",
       "  'message_text': \"### Recommendation for Moderna (MRNA):\\n\\n#### Key Strengths:\\n1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\\n2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\\n3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\\n\\n#### Key Weaknesses:\\n1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\\n2. **Below Key Moving Averages:** The current closing price (\\\\$68.28) is well below the 50-day (\\\\$95.88) and 200-day (\\\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\\n3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\\n\\n### Fit with Client's Investment Strategy:\\n- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\\n- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\\n\\n### Professional Recommendation:\\nBased on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\\n\\nPlease let me know if you need further detailed analysis or any additional information!\"},\n",
       " {'message_id': 'msg_qWHctlMUriq6M4P7fxWzr3t5',\n",
       "  'assistant_id': None,\n",
       "  'created_at': 1726350052,\n",
       "  'file_ids': [],\n",
       "  'role': 'user',\n",
       "  'run_id': None,\n",
       "  'message_text': \"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"},\n",
       " {'message_id': 'msg_6BDuEalmOKp190jDOumG56iB',\n",
       "  'assistant_id': 'asst_Mqf9cO1sDTOd4UMYwcFfIQrA',\n",
       "  'created_at': 1726350036,\n",
       "  'file_ids': [],\n",
       "  'role': 'assistant',\n",
       "  'run_id': 'run_mDRVe3YXrbCartQsh6C8rco9',\n",
       "  'message_text': \"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"}]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "thread.messages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "get_last_message initiated\n",
      "message_id: msg_zqvD0gadE9hib0XfNfbS57CC, assistant_id: asst_mPlBQ4ZF8YIF238DWqWRhV4U\n",
      "asst_id = blank\n",
      "new_message: ### Recommendation for Moderna (MRNA):\n",
      "\n",
      "#### Key Points:\n",
      "- **Current Price:** \\$68.28\n",
      "- **Volatility:** High\n",
      "- **Growth Potential:** Strong in mRNA technology\n",
      "- **Dividends:** None\n",
      "\n",
      "#### Recommendation:\n",
      "MRNA is suitable for growth-oriented investors willing to accept high risk for potential high returns. It may not be ideal for conservative or income-seeking investors due to its volatility and lack of dividends.\n",
      "\n",
      "Let me know if you need further details!\n",
      "message_id: msg_6hilKxJmcKKogiyy5s4RaL8u, assistant_id: None\n",
      "message.assistant_id != asst_id, record previous message first\n",
      "['### Recommendation for Moderna (MRNA):\\n\\n#### Key Points:\\n- **Current Price:** \\\\$68.28\\n- **Volatility:** High\\n- **Growth Potential:** Strong in mRNA technology\\n- **Dividends:** None\\n\\n#### Recommendation:\\nMRNA is suitable for growth-oriented investors willing to accept high risk for potential high returns. It may not be ideal for conservative or income-seeking investors due to its volatility and lack of dividends.\\n\\nLet me know if you need further details!']\n",
      "{'message_id': 'msg_zqvD0gadE9hib0XfNfbS57CC', 'assistant_id': 'asst_mPlBQ4ZF8YIF238DWqWRhV4U', 'created_at': 1726350085, 'file_ids': [], 'role': 'assistant', 'run_id': 'run_AFZhMbGJZSP5LrDRYHsMJDgD', 'message_text': '### Recommendation for Moderna (MRNA):\\n\\n#### Key Points:\\n- **Current Price:** \\\\$68.28\\n- **Volatility:** High\\n- **Growth Potential:** Strong in mRNA technology\\n- **Dividends:** None\\n\\n#### Recommendation:\\nMRNA is suitable for growth-oriented investors willing to accept high risk for potential high returns. It may not be ideal for conservative or income-seeking investors due to its volatility and lack of dividends.\\n\\nLet me know if you need further details!'}\n",
      "[]\n",
      "new_message: This message is for testing. Can you give a short sample response.\n",
      "['This message is for testing. Can you give a short sample response.']\n",
      "message_id: msg_T4gMWhbAIpFcj6D3f4WYcqCR, assistant_id: asst_mPlBQ4ZF8YIF238DWqWRhV4U\n",
      "message.assistant_id != asst_id, record previous message first\n",
      "['This message is for testing. Can you give a short sample response.']\n",
      "{'message_id': 'msg_6hilKxJmcKKogiyy5s4RaL8u', 'assistant_id': None, 'created_at': 1726350084, 'file_ids': [], 'role': 'user', 'run_id': None, 'message_text': 'This message is for testing. Can you give a short sample response.'}\n",
      "[]\n",
      "new_message: ### Recommendation for Moderna (MRNA):\n",
      "\n",
      "#### Key Strengths:\n",
      "1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\n",
      "2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\n",
      "3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\n",
      "\n",
      "#### Key Weaknesses:\n",
      "1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\n",
      "2. **Below Key Moving Averages:** The current closing price (\\$68.28) is well below the 50-day (\\$95.88) and 200-day (\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\n",
      "3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\n",
      "\n",
      "### Fit with Client's Investment Strategy:\n",
      "- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\n",
      "- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\n",
      "\n",
      "### Professional Recommendation:\n",
      "Based on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\n",
      "\n",
      "Please let me know if you need further detailed analysis or any additional information!\n",
      "[\"### Recommendation for Moderna (MRNA):\\n\\n#### Key Strengths:\\n1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\\n2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\\n3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\\n\\n#### Key Weaknesses:\\n1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\\n2. **Below Key Moving Averages:** The current closing price (\\\\$68.28) is well below the 50-day (\\\\$95.88) and 200-day (\\\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\\n3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\\n\\n### Fit with Client's Investment Strategy:\\n- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\\n- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\\n\\n### Professional Recommendation:\\nBased on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\\n\\nPlease let me know if you need further detailed analysis or any additional information!\"]\n",
      "message_id: msg_qWHctlMUriq6M4P7fxWzr3t5, assistant_id: None\n",
      "message.assistant_id != asst_id, record previous message first\n",
      "[\"### Recommendation for Moderna (MRNA):\\n\\n#### Key Strengths:\\n1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\\n2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\\n3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\\n\\n#### Key Weaknesses:\\n1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\\n2. **Below Key Moving Averages:** The current closing price (\\\\$68.28) is well below the 50-day (\\\\$95.88) and 200-day (\\\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\\n3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\\n\\n### Fit with Client's Investment Strategy:\\n- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\\n- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\\n\\n### Professional Recommendation:\\nBased on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\\n\\nPlease let me know if you need further detailed analysis or any additional information!\"]\n",
      "{'message_id': 'msg_T4gMWhbAIpFcj6D3f4WYcqCR', 'assistant_id': 'asst_mPlBQ4ZF8YIF238DWqWRhV4U', 'created_at': 1726350052, 'file_ids': [], 'role': 'assistant', 'run_id': 'run_CKU8trY0NhL8pRV5GpeNgbqC', 'message_text': \"### Recommendation for Moderna (MRNA):\\n\\n#### Key Strengths:\\n1. **Innovation Leader:** Moderna is a key player in mRNA technology, especially recognized for its COVID-19 vaccine, which has established its credibility and market presence.\\n2. **Growth Potential:** With continuing advancements in mRNA technology and potential new product pipelines, Moderna possesses significant growth potential.\\n3. **Strong Market Presence:** Noted for its vaccine and therapeutic developments, Moderna has established a strong market presence and brand recognition.\\n\\n#### Key Weaknesses:\\n1. **High Volatility:** As indicated by the historical data, MRNA stock has experienced substantial price fluctuations, leading to potentially higher risk.\\n2. **Below Key Moving Averages:** The current closing price (\\\\$68.28) is well below the 50-day (\\\\$95.88) and 200-day (\\\\$106.16) moving averages, which indicates a bearish trend and might be a red flag for conservative investors.\\n3. **Lack of Dividends:** Investors looking for steady income might be deterred by the lack of dividend payouts.\\n\\n### Fit with Client's Investment Strategy:\\n- **For Growth-Oriented Investors:** If the client is looking for growth and can tolerate volatility, MRNA may be a desirable addition. The company’s innovative edge and future growth prospects in the biotech sector are strong points.\\n- **For Risk-Averse or Income-Seeking Investors:** MRNA might not be suitable for clients seeking steady income or those who are risk-averse due to its high volatility, current downward trend, and lack of dividends.\\n\\n### Professional Recommendation:\\nBased on the data analysis and the evaluation of strengths and weaknesses, **Moderna (MRNA) could be a good fit for growth-oriented investors willing to accept higher risk for potential high rewards**. However, it may not be suitable for conservative investors or those looking for consistent dividend income.\\n\\nPlease let me know if you need further detailed analysis or any additional information!\"}\n",
      "[]\n",
      "new_message: Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "The provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\n",
      "- Date\n",
      "- Open\n",
      "- High\n",
      "- Low\n",
      "- Close\n",
      "- Volume\n",
      "- Dividends\n",
      "- Stock Splits\n",
      "- Ticker\n",
      "\n",
      "### Steps for Analysis:\n",
      "1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\n",
      "2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\n",
      "3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\n",
      "4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\n",
      "\n",
      "Let's start by performing these analyses.\n",
      "Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "### Analysis Summary for Moderna (MRNA):\n",
      "\n",
      "#### Historical Price Analysis:\n",
      "- **Current Closing Price:** \\$68.28\n",
      "- **Average Close Price:** \\$118.85 (over the analyzed period)\n",
      "- **52-Week High:** \\$484.47\n",
      "- **52-Week Low:** \\$12.26\n",
      "\n",
      "#### Moving Averages:\n",
      "- **50-Day Moving Average (MA_50):** \\$95.88\n",
      "- **200-Day Moving Average (MA_200):** \\$106.16\n",
      "\n",
      "#### Volume Analysis:\n",
      "- **Average Daily Trading Volume:** 8.08 million shares\n",
      "- **High Trading Volume:** Up to 125.13 million shares\n",
      "- **Low Trading Volume:** As low as 272.8 thousand shares\n",
      "\n",
      "#### Volatility:\n",
      "- **Standard Deviation of Daily Returns:** 4.63%\n",
      "- **Average Daily Return:** 0.20%\n",
      "- **Daily Return Range:** -21.01% to 27.81%\n",
      "\n",
      "### Key Observations:\n",
      "- The current price of \\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\n",
      "- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\n",
      "- No dividend payouts or stock splits have been recorded historically for MRNA.\n",
      "\n",
      "The financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\n",
      "[\"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"]\n",
      "message_id: msg_ATqDH6NCl043TLvKdGCdSGyr, assistant_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id != asst_id, record previous message first\n",
      "[\"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"]\n",
      "{'message_id': 'msg_qWHctlMUriq6M4P7fxWzr3t5', 'assistant_id': None, 'created_at': 1726350052, 'file_ids': [], 'role': 'user', 'run_id': None, 'message_text': \"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"}\n",
      "[]\n",
      "new_message: Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "### Analysis Summary for Moderna (MRNA):\n",
      "\n",
      "#### Historical Price Analysis:\n",
      "- **Current Closing Price:** \\$68.28\n",
      "- **Average Close Price:** \\$118.85 (over the analyzed period)\n",
      "- **52-Week High:** \\$484.47\n",
      "- **52-Week Low:** \\$12.26\n",
      "\n",
      "#### Moving Averages:\n",
      "- **50-Day Moving Average (MA_50):** \\$95.88\n",
      "- **200-Day Moving Average (MA_200):** \\$106.16\n",
      "\n",
      "#### Volume Analysis:\n",
      "- **Average Daily Trading Volume:** 8.08 million shares\n",
      "- **High Trading Volume:** Up to 125.13 million shares\n",
      "- **Low Trading Volume:** As low as 272.8 thousand shares\n",
      "\n",
      "#### Volatility:\n",
      "- **Standard Deviation of Daily Returns:** 4.63%\n",
      "- **Average Daily Return:** 0.20%\n",
      "- **Daily Return Range:** -21.01% to 27.81%\n",
      "\n",
      "### Key Observations:\n",
      "- The current price of \\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\n",
      "- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\n",
      "- No dividend payouts or stock splits have been recorded historically for MRNA.\n",
      "\n",
      "The financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\n",
      "['Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.']\n",
      "message_id: msg_6BDuEalmOKp190jDOumG56iB, assistant_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id == asst_id, proceed normally to collect message\n",
      "new_message: Here are the information gathered from the financial analyst: \n",
      "These are the stocks the client wants advice on: \n",
      "- MRNA\n",
      "\n",
      "The provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\n",
      "- Date\n",
      "- Open\n",
      "- High\n",
      "- Low\n",
      "- Close\n",
      "- Volume\n",
      "- Dividends\n",
      "- Stock Splits\n",
      "- Ticker\n",
      "\n",
      "### Steps for Analysis:\n",
      "1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\n",
      "2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\n",
      "3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\n",
      "4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\n",
      "\n",
      "Let's start by performing these analyses.\n",
      "message_id: msg_dy4lz80kcSMTj2CPUe5fyIXq, assistant_id: None\n",
      "message.id in existing_message_id, ending function\n",
      "{'message_id': 'msg_6BDuEalmOKp190jDOumG56iB', 'assistant_id': 'asst_Mqf9cO1sDTOd4UMYwcFfIQrA', 'created_at': 1726350036, 'file_ids': [], 'role': 'assistant', 'run_id': 'run_mDRVe3YXrbCartQsh6C8rco9', 'message_text': \"Here are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\nThe provided data includes daily stock prices for Moderna (MRNA), covering the following columns:\\n- Date\\n- Open\\n- High\\n- Low\\n- Close\\n- Volume\\n- Dividends\\n- Stock Splits\\n- Ticker\\n\\n### Steps for Analysis:\\n1. **Historical Price Analysis:** Assess the price trends, volatility, and key support/resistance levels over a defined period.\\n2. **Volume Analysis:** Evaluate the trading volume to understand market interest and liquidity.\\n3. **Dividend and Split Analysis:** While MRNA currently shows no dividend or stock splits, we will confirm if this continues historically.\\n4. **Statistical Measures:** Calculate key metrics such as Moving Averages and standard deviation.\\n\\nLet's start by performing these analyses.\\nHere are the information gathered from the financial analyst: \\nThese are the stocks the client wants advice on: \\n- MRNA\\n\\n### Analysis Summary for Moderna (MRNA):\\n\\n#### Historical Price Analysis:\\n- **Current Closing Price:** \\\\$68.28\\n- **Average Close Price:** \\\\$118.85 (over the analyzed period)\\n- **52-Week High:** \\\\$484.47\\n- **52-Week Low:** \\\\$12.26\\n\\n#### Moving Averages:\\n- **50-Day Moving Average (MA_50):** \\\\$95.88\\n- **200-Day Moving Average (MA_200):** \\\\$106.16\\n\\n#### Volume Analysis:\\n- **Average Daily Trading Volume:** 8.08 million shares\\n- **High Trading Volume:** Up to 125.13 million shares\\n- **Low Trading Volume:** As low as 272.8 thousand shares\\n\\n#### Volatility:\\n- **Standard Deviation of Daily Returns:** 4.63%\\n- **Average Daily Return:** 0.20%\\n- **Daily Return Range:** -21.01% to 27.81%\\n\\n### Key Observations:\\n- The current price of \\\\$68.28 is significantly lower than both the 50-day and 200-day moving averages, suggesting a bearish trend.\\n- MRNA has experienced high volatility and substantial fluctuations in trading volumes.\\n- No dividend payouts or stock splits have been recorded historically for MRNA.\\n\\nThe financial advisor can use this objective data analysis to tailor specific recommendations for the client based on the current market performance and trend indicators.\"}\n"
     ]
    }
   ],
   "source": [
    "# existing_message_id = [dic['message_id'] for dic in thread.messages]\n",
    "\n",
    "a = thread.messages[0]\n",
    "\n",
    "thread.messages = []\n",
    "\n",
    "thread.messages.append(a)\n",
    "\n",
    "thread.get_last_message()\n",
    "# thread.messages[-1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "message_id: msg_0YI1I3hF8OTzcEOG98L7Yi1V, asst_id: asst_mPlBQ4ZF8YIF238DWqWRhV4U\n",
      "asst_id = blank\n",
      "message_id: msg_QAPBtXXNgWnzX53d7SuW9dfQ, asst_id: None\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_QVoKLLa1XshONulTZ3ZGpgwI, asst_id: asst_mPlBQ4ZF8YIF238DWqWRhV4U\n",
      "message.assistant_id == asst_id, proceed normally\n",
      "message_id: msg_H8VId2krDKV9oKD0G0ao59lF, asst_id: None\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_Q5q5yM7L3n4Ng7F77GADFKON, asst_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_WJz18bE75m6GBxFfevGa0tgp, asst_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_itcdIzYvUErWcQaIbUeoNEAx, asst_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_uZbO2pgmoVS0p4i28XPKymwo, asst_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_uRhuw9hwoL1VxwJmgCAbCD0f, asst_id: asst_Mqf9cO1sDTOd4UMYwcFfIQrA\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_JJrhDEaNLS0Ub0KvebldCgTq, asst_id: None\n",
      "message.assistant_id != asst_id, start a new round of message\n",
      "message_id: msg_L6Wif9U3Q61V6tEVqjC9ltJD, asst_id: None\n",
      "id exists\n"
     ]
    }
   ],
   "source": [
    "# existing_message_id = [dic['message_id'] for dic in thread.messages]\n",
    "asst_id = ''\n",
    "\n",
    "for message in messages_data:\n",
    "\n",
    "\tprint(f'message_id: {message.id}, asst_id: {message.assistant_id}')\n",
    "\n",
    "\tif message.id in existing_message_id:\n",
    "\t\tprint('id exists')\n",
    "\n",
    "\telse:\n",
    "\t\t# print('id doesnt exist')\n",
    "\t\tif asst_id == '':\n",
    "\t\t\tprint('asst_id = blank')\n",
    "\n",
    "\t\t\tasst_id = message.assistant_id\n",
    "\n",
    "\t\telif message.assistant_id == asst_id:\n",
    "\n",
    "\t\t\tprint('message.assistant_id == asst_id, proceed normally')\n",
    "\n",
    "\t\telse:\n",
    "\n",
    "\t\t\tprint('message.assistant_id != asst_id, start a new round of message')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "thread: thread_jq2tOUGEzC8Jp7jdePpkkgo7 has been deleted.\n"
     ]
    }
   ],
   "source": [
    "thread.delete_thread()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
